Latest JOHNSON & JOHNSON Stock Portfolio
$4.39Billion
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About JOHNSON & JOHNSON and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, JOHNSON & JOHNSON reported an equity portfolio of $271.5 Millions as of 30 Sep, 2023.
The top stock holdings of JOHNSON & JOHNSON are , CVRX, PTGX. The fund has invested 20.2% of it's portfolio in LEGEND BIOTECH CORPORATION and 19.5% of portfolio in CVRX, INC.
JOHNSON & JOHNSON opened new stock positions in NEUMORA THERAPEUTICS, INC..
The top stock holdings of JOHNSON & JOHNSON are , CVRX, PTGX. The fund has invested 20.2% of it's portfolio in LEGEND BIOTECH CORPORATION and 19.5% of portfolio in CVRX, INC.
JOHNSON & JOHNSON opened new stock positions in NEUMORA THERAPEUTICS, INC..
New Buys
| Ticker | $ Bought |
|---|---|
| KENVUE INC. | 3,925,560,000 |
| SHOCKWAVE MEDICAL, INC. | 31,787,700 |
New stocks bought by JOHNSON & JOHNSON
Additions
| Ticker | % Inc. |
|---|---|
| NANOBIOTIX S.A. | 486 |
| NEUMORA THERAPEUTICS, INC. | 102 |
Additions to existing portfolio by JOHNSON & JOHNSON
Reductions
| Ticker | % Reduced |
|---|---|
| ALDEYRA THERAPEUTICS, INC. | -24.1 |
| ADICET BIO, INC. | -5.54 |
JOHNSON & JOHNSON reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| CUE HEALTH, INC. | -2,454,260 |
| POINT BIOPHARMA GLOBAL INC. | -6,670,000 |
| CATALYST BIOSCIENCES, INC. | -32,290 |
JOHNSON & JOHNSON got rid off the above stocks
Current Stock Holdings of JOHNSON & JOHNSON
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| ACET | ADICET BIO, INC. | 0.03 | 688,595 | 1,301,440 | REDUCED | -5.54 | |
| ALDX | ALDEYRA THERAPEUTICS, INC. | 0.02 | 299,669 | 1,051,840 | REDUCED | -24.1 | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | 0.17 | 247,598 | 7,576,500 | UNCHANGED | 0.00 | |
| CBIO | CATALYST BIOSCIENCES, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CLSD | CLEARSIDE BIOMEDICAL, INC. | 0.00 | 169,629 | 198,466 | UNCHANGED | 0.00 | |
| CVRX | CVRX, INC. | 2.51 | 3,495,580 | 109,901,000 | UNCHANGED | 0.00 | |
| FATE | FATE THERAPEUTICS, INC. | 0.29 | 3,379,060 | 12,637,700 | UNCHANGED | 0.00 | |
| FUSN | FUSION PHARMACEUTICALS INC. | 0.80 | 3,670,520 | 35,273,700 | UNCHANGED | 0.00 | |
| HLTH | CUE HEALTH, INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| LEGN | LEGEND BIOTECH CORPORATION | 1.12 | 814,586 | 49,013,600 | UNCHANGED | 0.00 | |
| MGTX | MEIRAGTX HOLDINGS PLC | 1.06 | 6,641,060 | 46,620,300 | UNCHANGED | 0.00 | |
| NBTX | NANOBIOTIX S.A. | 0.93 | 5,623,820 | 40,941,400 | ADDED | 486 | |
| NNOX | NANO-X IMAGING LTD. | 0.05 | 317,704 | 2,023,770 | UNCHANGED | 0.00 | |
| PHGE | BIOMX INC. | 0.01 | 2,133,400 | 597,353 | UNCHANGED | 0.00 | |
| PNT | POINT BIOPHARMA GLOBAL INC. | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PRCT | PROCEPT BIOROBOTICS CORPORATION | 0.34 | 357,939 | 15,001,200 | UNCHANGED | 0.00 | |
| PTGX | PROTAGONIST THERAPEUTICS INC. | 1.28 | 2,449,180 | 56,159,800 | UNCHANGED | 0.00 | |
| SENS | SENSEONICS HOLDINGS, INC. | 0.00 | 54,621 | 31,139 | UNCHANGED | 0.00 | |
| SLGC | SOMALOGIC, INC. | 0.02 | 281,052 | 711,062 | UNCHANGED | 0.00 | |
| SWAV | SHOCKWAVE MEDICAL, INC. | 0.72 | 166,812 | 31,787,700 | NEW | ||
| TCON | TRACON PHARMACEUTICALS, INC. | 0.00 | 84,003 | 14,709 | UNCHANGED | 0.00 | |
| VOR | VOR BIOPHARMA, INC. | 0.06 | 1,074,660 | 2,417,980 | UNCHANGED | 0.00 | |
| XNCR | XENCOR, INC. | 0.36 | 748,062 | 15,881,400 | UNCHANGED | 0.00 | |
| KENVUE INC. | 89.50 | 182,330,000 | 3,925,560,000 | NEW | |||
| NEUMORA THERAPEUTICS, INC. | 0.72 | 1,849,440 | 31,533,000 | ADDED | 102 | ||
| APOLLOMICS, INC. | 0.00 | 13,252 | 12,788 | UNCHANGED | 0.00 |